Raju Subramanian

Title: Raju Subramanian: Innovator in Pharmaceutical Chemistry

Introduction

Raju Subramanian is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on creating effective treatments for various diseases, showcasing his dedication to advancing healthcare.

Latest Patents

Raju Subramanian holds a patent for "Benzomorpholine derivatives and methods of use." This patent includes selected benzomorpholine compounds, such as 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-(5-methyl-3-isoxazolyl)-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide. These compounds are effective for the prophylaxis and treatment of diseases, particularly those mediated by VEGF. The invention encompasses novel compounds, analogs, prodrugs, and pharmaceutically acceptable salts, along with pharmaceutical compositions and methods for treating conditions like cancer. Additionally, the patent details processes for making these compounds and the intermediates useful in such processes.

Career Highlights

Raju Subramanian is currently employed at Amgen Inc., a leading biotechnology company. His role at Amgen allows him to leverage his expertise in pharmaceutical chemistry to contribute to innovative solutions in healthcare. His work has been instrumental in developing new therapeutic options for patients.

Collaborations

Throughout his career, Raju has collaborated with esteemed colleagues, including Jean-Christophe P Harmange and Matthew W Martin. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Raju Subramanian is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of serious diseases. His innovative approach and dedication to research exemplify the importance of invention in advancing medical science.